![Key Report](https://beam-alliance.eu/assets/images/key-reports.png")
CGD – Economic Impacts of Antimicrobial Resistance in Humans
AMR burden, Economy, Health
Key Reports
- AMR burden (2)
- Pipeline (4)
- PULL incentives (15)
- Antibacterials (1)
- Economy (4)
- Financing models (2)
- Health (2)
- Other PULL (4)
- Pricing & Reimbursement (2)
- Priority pathogens (2)
- PUSH incentives (1)
- Size & ROI (6)
- Subscription (5)
- Vaccines (1)
- Value-based (2)
- Voucher (6)
No results
1 / 4
